136 related articles for article (PubMed ID: 29665662)
1. [Association of single nucleotide polymorphisms of tissue factor and tissue factor pathway inhibitor with venous thromboembolism in patients with lung cancer].
Zhang XL; Zhu J; Chen WH; Zhai ZG; Zhang YH
Zhonghua Yi Xue Za Zhi; 2018 Mar; 98(12):901-906. PubMed ID: 29665662
[No Abstract] [Full Text] [Related]
2. Genetic polymorphisms and plasma levels of tissue factor and tissue factor pathway inhibitor in venous thromboembolism.
Kwon A; Jo SH; Jo YA; Park JY; Kim M; Kang HJ; Kim HS; Cho HC; Lee YK
Blood Coagul Fibrinolysis; 2014 Jul; 25(5):416-21. PubMed ID: 24448154
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.
Lincz LF; Adams MJ; Scorgie FE; Thom J; Baker RI; Seldon M
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):559-64. PubMed ID: 17762532
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of tissue factor -603A/G and +5466A>G polimorphisms at the development of venous thromboembolism in cancer patients.
Eroğlu A; Ceylan GG; Ozturk E; Yalcin A; Yalcin B; Karasoy D
Exp Oncol; 2016 Sep; 38(3):187-90. PubMed ID: 27685527
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy.
Opstad TB; Eilertsen AL; Høibraaten E; Skretting G; Sandset PM
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):516-21. PubMed ID: 20453636
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of polymorphisms in the human TFPI gene.
Skretting G; Stavik B; Landvik NE; Myklebust CF; Iversen N; Zienolddiny S; Sandset PM
Biochem Biophys Res Commun; 2010 Jun; 397(1):106-11. PubMed ID: 20519147
[TBL] [Abstract][Full Text] [Related]
7. Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer- relationship with venous thrombosis risk.
Abu Saadeh F; Norris L; O'Toole S; Mohamed BM; Langhe R; O'Leary J; Gleeson N
Thromb Res; 2013 Nov; 132(5):627-34. PubMed ID: 24094893
[TBL] [Abstract][Full Text] [Related]
8. Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes.
Opstad TB; Pettersen AA; Weiss T; Arnesen H; Seljeflot I
Thromb J; 2010 May; 8():7. PubMed ID: 20444258
[TBL] [Abstract][Full Text] [Related]
9. Tissue Factor Pathway Inhibitor Gene Polymorphism -33T → C Predicts Improved Disease-Free Survival in Colorectal Cancer.
Bazzarelli AK; Scheer AS; Tai LH; Seth R; de Souza CT; Petrcich W; Jonker DJ; Maroun JA; Carrier M; Auer RC
Ann Surg Oncol; 2016 Jul; 23(7):2274-80. PubMed ID: 26968713
[TBL] [Abstract][Full Text] [Related]
10. The -33T-->C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations.
Ameziane N; Seguin C; Borgel D; Fumeron F; Moatti D; Alhenc-Gelas M; Grandchamp B; Aiach M; Emmerich J; de Prost D
Thromb Haemost; 2002 Aug; 88(2):195-9. PubMed ID: 12195688
[TBL] [Abstract][Full Text] [Related]
11. Influence of tissue factor polymorphisms (603A>G and 5466A>G) on plasma tissue factor levels and their impact on deep vein thrombosis risk in young Indian population.
Kishor K; Sharma A; Singh K; Ranjan R; Pandey H; Kumar R; Kamal VK; Mishra P; Mahapatra M; Saxena R
J Thromb Thrombolysis; 2018 Jul; 46(1):88-94. PubMed ID: 29789989
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in antithrombin and in tissue factor pathway inhibitor genes are associated with recurrent pregnancy loss.
Guerra-Shinohara EM; Bertinato JF; Tosin Bueno C; Cordeiro da Silva K; Burlacchini de Carvalho MH; Pulcineli Vieira Francisco R; Zugaib M; Cerda A; Morelli VM
Thromb Haemost; 2012 Oct; 108(4):693-700. PubMed ID: 22918506
[TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism.
Dennis J; Truong V; Aïssi D; Medina-Rivera A; Blankenberg S; Germain M; Lemire M; Antounians L; Civelek M; Schnabel R; Wells P; Wilson MD; Morange PE; Trégouët DA; Gagnon F
J Thromb Haemost; 2016 Oct; 14(10):1960-1970. PubMed ID: 27490645
[TBL] [Abstract][Full Text] [Related]
14. Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.
Tinholt M; Vollan HK; Sahlberg KK; Jernström S; Kaveh F; Lingjærde OC; Kåresen R; Sauer T; Kristensen V; Børresen-Dale AL; Sandset PM; Iversen N
Breast Cancer Res; 2015 Mar; 17(1):44. PubMed ID: 25882602
[TBL] [Abstract][Full Text] [Related]
15. Leveraging cell type specific regulatory regions to detect SNPs associated with tissue factor pathway inhibitor plasma levels.
Dennis J; Medina-Rivera A; Truong V; Antounians L; Zwingerman N; Carrasco G; Strug L; Wells P; Trégouët DA; Morange PE; Wilson MD; Gagnon F
Genet Epidemiol; 2017 Jul; 41(5):455-466. PubMed ID: 28421636
[TBL] [Abstract][Full Text] [Related]
16. Analysis of a T-287C polymorphism in the tissue factor pathway inhibitor gene and identification of a repressor element in the promoter.
Amini Nekoo A; Iles D
Thromb Res; 2008; 121(6):813-9. PubMed ID: 17931693
[TBL] [Abstract][Full Text] [Related]
17. Haplotypes of TAFI gene and the risk of cerebral venous thrombosis--a case-control study.
Orikaza CM; Morelli VM; Matos MF; Lourenço DM
Thromb Res; 2014 Jan; 133(1):120-4. PubMed ID: 24252537
[TBL] [Abstract][Full Text] [Related]
18. Association of genetic polymorphisms with plasma TFPI level: Boon or curse for DVT patients - Study from India.
Kamal K; Amit S; Kanwaljeet S; Ravi R; Hareram P; Ravi K; Kumar KV; Pravas M; Renu S
Blood Cells Mol Dis; 2017 Jul; 66():31-36. PubMed ID: 28810169
[TBL] [Abstract][Full Text] [Related]
19. High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer.
Wang M; Huang X; Zhu M; Zhang S; Zhang Y
Clin Respir J; 2020 May; 14(5):481-487. PubMed ID: 32031323
[TBL] [Abstract][Full Text] [Related]
20. Role of monocyte tissue factor on patients with non-small cell lung cancer.
Deng C; Wu S; Zhang L; Yang M; Lin Q; Xie Q; Ding H; Lian N; Gao S; Huang Y; Jin Y
Clin Respir J; 2018 Mar; 12(3):1125-1133. PubMed ID: 28419722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
